259 related articles for article (PubMed ID: 32200338)
21. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis.
Wang N; Zhang SN; Xing RJ; Liu MQ; Huang CN; Jiang SM; Li T; Yang CS; Yang L; Zhang LJ
Mult Scler Relat Disord; 2021 Jan; 47():102629. PubMed ID: 33232908
[TBL] [Abstract][Full Text] [Related]
24. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
Messina S; Mariano R; Roca-Fernandez A; Cavey A; Jurynczyk M; Leite MI; Calabrese M; Jenkinson M; Palace J
Mult Scler; 2022 Feb; 28(2):217-227. PubMed ID: 34048323
[TBL] [Abstract][Full Text] [Related]
25. Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Pache F; Zimmermann H; Finke C; Lacheta A; Papazoglou S; Kuchling J; Wuerfel J; Hamm B; Ruprecht K; Paul F; Brandt AU; Scheel M
Eur Radiol; 2016 Dec; 26(12):4413-4422. PubMed ID: 27012555
[TBL] [Abstract][Full Text] [Related]
26. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
[TBL] [Abstract][Full Text] [Related]
27. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
[TBL] [Abstract][Full Text] [Related]
28. Neuromyelitis optica: a diffusional kurtosis imaging study.
Doring TM; Lopes FC; Kubo TT; Tukamoto G; Kimura MC; Strecker RM; Domingues RC; Gasparetto EL
AJNR Am J Neuroradiol; 2014 Dec; 35(12):2287-92. PubMed ID: 25082817
[TBL] [Abstract][Full Text] [Related]
29. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
[TBL] [Abstract][Full Text] [Related]
30. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.
Hagiwara A; Otsuka Y; Andica C; Kato S; Yokoyama K; Hori M; Fujita S; Kamagata K; Hattori N; Aoki S
J Clin Neurosci; 2021 May; 87():55-58. PubMed ID: 33863534
[TBL] [Abstract][Full Text] [Related]
31. Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Kuwabara S
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):32-40. PubMed ID: 34362853
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
33. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
Eur Radiol; 2024 Jan; ():. PubMed ID: 38175221
[TBL] [Abstract][Full Text] [Related]
34. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
[TBL] [Abstract][Full Text] [Related]
35. Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
von Glehn F; Jarius S; Cavalcanti Lira RP; Alves Ferreira MC; von Glehn FH; Costa E Castro SM; Beltramini GC; Bergo FP; Farias AS; Brandão CO; Wildemann B; Damasceno BP; Cendes F; Santos LM; Yasuda CL
Mult Scler; 2014 Aug; 20(9):1189-97. PubMed ID: 24477120
[TBL] [Abstract][Full Text] [Related]
36. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
37. Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
You Y; Zhu L; Zhang T; Shen T; Fontes A; Yiannikas C; Parratt J; Barton J; Schulz A; Gupta V; Barnett MH; Fraser CL; Gillies M; Graham SL; Klistorner A
Ophthalmology; 2019 Jun; 126(6):801-810. PubMed ID: 30711604
[TBL] [Abstract][Full Text] [Related]
38. Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
Liu Y; Duan Y; Huang J; Ren Z; Ye J; Dong H; Shi FD; Barkhof F; Vrenken H; Wattjes MP; Wang J; Li K
Radiology; 2015 Dec; 277(3):784-92. PubMed ID: 26043265
[TBL] [Abstract][Full Text] [Related]
39. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Kawachi I; Nishizawa M
Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808
[TBL] [Abstract][Full Text] [Related]
40. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
